MRTTSE:6034 63 Net Margin % is -8.78% as of Mar. 2026. GuruFocus rates TSE:6034 with a GF Score™ of 63/100 and a GF Value™ of 円635.93 (Fairly Valued). The stock has 4 warning signs investors should review. Among 666 Healthcare Providers & Services companies, MRT ranks worse than 53.9% on this metric.
Net margin is calculated as Net Income divided by its Revenue. MRT's Net Income for the
three
months ended in Mar. 2026 was 円-80 Mil. MRT's Revenue for the
three
months ended in Mar. 2026 was 円907 Mil. Therefore, MRT's net margin for the quarter that ended in Mar. 2026 was -8.78%.
The historical rank and industry rank for MRT's Net Margin % or its related term are showing as below:
TSE:6034'
s Net Margin % Range Over the Past 10 Years
Min: -7.42 Med: 6.39 Max: 24.72
Current: 2.03
TSE:6034's Net Margin % is ranked worse than 53.9% of 666
companies
in the Healthcare Providers & Services industry
Industry Median: 2.915
vs TSE:6034: 2.03
MRT (TSE:6034) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
MRT Net Margin % Related Terms
MRT Net Margin % Historical Data
* Premium members only.
The historical data trend for MRT's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:6034 vs HCA, THC, DVA: Net Margin % Comparison
For the Medical Care Facilities subindustry, MRT's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MRT Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MRT's Net Margin % distribution charts can be found below:
* The bar in red indicates where MRT's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MRT (TSE:6034) has a Net Margin % of -8.78% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on MRT and its competitors. According to the industry distribution chart, MRT ranks #359 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 53.9%.
Is MRT's Net Margin % too high?
MRT's current Net Margin % is -8.78%. Based on the distribution chart, MRT ranks #359 out of 666 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, MRT has a GF Score™ of 63/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does MRT's Net Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, MRT ranks #359 out of 666 companies for Net Margin %. This places MRT in the lower half of its industry. The industry median Net Margin % is 2.92. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.92, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on MRT and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MRT's current Net Margin % is -8.78%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MRT stock overvalued right now?
Based on GuruFocus' analysis, MRT (TSE:6034) is currently considered Fairly Valued. The stock's GF Value™ is 円635.93, compared to a current price of 円630.00 — trading 0.9% below its estimated fair value. The current Net Margin % is -8.78%. MRT's overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For MRT (TSE:6034), the current Net Margin % is -8.78% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MRT (TSE:6034) Overvalued in 2026?
Based on GuruFocus' analysis, MRT stock appears to be undervalued.
The current stock price of 円630.00 is trading 0.9% below its estimated GF Value™ of 円635.93.
GuruFocus considers MRT to be Fairly Valued.
Key valuation signals for TSE:6034:
Net Margin %: -8.78%
GF Value™: 円635.93 vs. price of 円630.00 (0.9% below fair value)
No single metric tells the full story. See the TSE:6034 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MRT Inc engages in the business of medical personnel placement services through the Internet. It provides part-time and full-time physician referral services through the physician referral site, as well as part-time job referral, job change introduction services to nurses, pharmacists, clinical laboratory technicians, clinical engineers, and radiologists. Further, the company engages in the research and development of analytical and analytical methods for various biological samples, such as microorganisms, blood, proteins, and genes; and research and development, manufacture, and sale of medical and medical examination equipment, and analytical instruments.
63GF Score
Get the complete analysis for TSE:6034
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6034 has been successfully added to your 
